È£¸£¸ó ÇÇÀÓ¾à ½ÃÀå : ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, ¹æ¹ýº°, È£¸£¸óº°, Áö¿ªº°, °æÀﺰ ºÎ¹®, 2020-2030³â
Hormonal Contraceptives Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Method, By Hormone, By Region and Competition, 2020-2030F
»óǰÄÚµå : 1797060
¸®¼­Ä¡»ç : TechSci Research
¹ßÇàÀÏ : 2025³â 08¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 185 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,333,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 5,500 £Ü 7,741,000
PDF and Excel (Multi-User License) help
PDF ¹× Excel º¸°í¼­¸¦ ±â¾÷ÀÇ ÆÀÀ̳ª ±â°ü¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,000 £Ü 11,260,000
PDF and Excel (Custom Research License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ¹× Excel ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù. 80½Ã°£ÀÇ ¾Ö³Î¸®½ºÆ® ŸÀÓÀÌ Æ÷ÇԵǾî ÀÖ°í Copy & Paste °¡´ÉÇÑ PPT ¹öÀüµµ Á¦°øµË´Ï´Ù. ªÀº Bespoke ¸®¼­Ä¡ ÇÁ·ÎÁ§Æ® ¼öÇà¿¡ ¸Â´Â ¶óÀ̼±½ºÀÔ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ È£¸£¸ó ÇÇÀÓ¾à ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 172¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇϸç, ¿¹Ãø ±â°£ Áß CAGRÀº 6.78%·Î 2030³â¿¡´Â 255¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ È£¸£¸ó ÇÇÀÓ¾à ½ÃÀåÀº °æ±¸ ÇÇÀÓ¾à »ç¿ë¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í, ÀǵµÆÄ°ü ¾ÊÀº ÀӽŠ¿¹¹æ ¹× Àα¸ ¾ïÁ¦ È¿°ú·Î ÀÎÇØ Àü ¼¼°è ¿©·¯ Áö¿ª¿¡¼­ È£¸£¸ó ÇÇÀӾ࿡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϸ鼭 Å« ÆøÀ¸·Î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ È£¸£¸ó ÇÇÀÓ¾àÀÇ Ã¤ÅÃÀÌ Å©°Ô Áõ°¡Çϰí ÀÖÀ¸¸ç, ´Ù¾çÇÑ ¿¬·É´ëÀÇ ¿©¼ºµé »çÀÌ¿¡¼­ ¾ÈÀüÇÑ »ýȰ¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó °¢Á¾ È£¸£¸ó ÇÇÀÓ¹ý¿¡ ´ëÇÑ ¼ö¿ä´Â ¾ÕÀ¸·Î ´õ¿í È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹¸¦ µé¾î 2021³â 4¿ù ¸ÞÀÌ³× ÆÄ¸¶(Mayne Pharma)°¡ ÆÇ¸ÅÇÏ´Â ÀӽŠ¿¹¹æ¿ë µå·Î½ºÇÇ·¹³í°ú ¿¡½ºÆ®¶óÅ×·Ñ º¹ÇÕÁ¦ Nextstellis°¡ ½ÄǰÀǾàǰ¾ÈÀüóÀÇ ½ÂÀÎÀ» ¹Þ¾Ò´Âµ¥, À̴ õ¿¬ À¯·¡ ¿¡½ºÆ®·Î°ÕÀ» ÇÔÀ¯ÇÑ ÃÖÃÊÀÇ º¹ÇÕÁ¦ Áß ÇϳªÀÔ´Ï´Ù.

½ÃÀå °³¿ä
¿¹Ãø ±â°£ 2026-2030³â
½ÃÀå ±Ô¸ð : 2024³â 172¾ï 5,000¸¸ ´Þ·¯
½ÃÀå ±Ô¸ð : 2030³â 255¾ï 7,000¸¸ ´Þ·¯
CAGR : 2025-2030³â 6.78%
±Þ¼ºÀå ºÎ¹® ÇÁ·Î°Ô½ºÆ¾ ¿Â¸®
ÃÖ´ë ½ÃÀå ºÏ¹Ì

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

°¡Á· °èȹ ¹× »ý½Ä °Ç°­ ÁõÁøÀ» À§ÇÑ Á¤ºÎ ±¸»ó Áõ°¡

ÁÖ¿ä ½ÃÀå À̽´

È£¸£¸ó ÇÇÀÓ¾à°ú °ü·ÃµÈ °Ç°­ À§Çè°ú ºÎÀÛ¿ëÀº?

ÁÖ¿ä ½ÃÀå µ¿Çâ

Àå±âÁö¼ÓÇü °¡¿ªÀû ÇÇÀÓ¾à(LARC)¿¡ ´ëÇÑ ¼±È£µµ Áõ°¡

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå °³¿ä

Á¦4Àå °í°´ÀÇ ¼Ò¸®

Á¦5Àå ÀÓ»ó½ÃÇè ºÐ¼®

Á¦6Àå ¼¼°èÀÇ È£¸£¸ó ÇÇÀÓ¾à ½ÃÀå Àü¸Á

Á¦7Àå ºÏ¹ÌÀÇ È£¸£¸ó ÇÇÀÓ¾à ½ÃÀå Àü¸Á

Á¦8Àå À¯·´ÀÇ È£¸£¸ó ÇÇÀÓ¾à ½ÃÀå Àü¸Á

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ È£¸£¸ó ÇÇÀÓ¾à ½ÃÀå Àü¸Á

Á¦10Àå ³²¹ÌÀÇ È£¸£¸ó ÇÇÀÓ¾à ½ÃÀå Àü¸Á

Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ È£¸£¸ó ÇÇÀÓ¾à ½ÃÀå Àü¸Á

Á¦12Àå ½ÃÀå ¿ªÇÐ

Á¦13Àå ½ÃÀå µ¿Çâ°ú ¹ßÀü

Á¦14Àå Porter's Five Forces ºÐ¼®

Á¦15Àå SWOT ºÐ¼® : ¼¼°èÀÇ È£¸£¸ó ÇÇÀÓ¾à ½ÃÀå

Á¦16Àå °æÀï ±¸µµ

Á¦17Àå Àü·«Àû Á¦¾È

Á¦18Àå Á¶»çȸ»ç ¼Ò°³¡¤¸éÃ¥»çÇ×

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Hormonal Contraceptives Market was valued at USD 17.25 Billion in 2024 and is expected to reach USD 25.57 Billion by 2030 with a CAGR of 6.78% during the forecast period. The global market for Hormonal Contraceptives is experiencing significant growth, driven by the growing awareness regarding usage of oral contraceptive and its benefits for preventing the unintended pregnancy and population control significantly increased the demand for hormonal contraceptives across different parts of the globe. Additionally, ahavetion of hormonal contraceptives has significantly increased and increasing awareness among women of different age group for leading the safe life is further expected to increase the demand for different hormonal contraceptives procedures, thereby fuelling the market growth. For instance, in April 2021, the Food and Drug Administration approved a combination of drospirenone and estetrol tablet Nextstellis marketed by Mayne Pharma for preventing pregnancy, one of the first combination pills containing naturally occurring estrogen.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 17.25 Billion
Market Size 2030USD 25.57 Billion
CAGR 2025-20306.78%
Fastest Growing SegmentProgestin Only
Largest MarketNorth America

Key Market Drivers

Rising Government Initiatives to Promote Family Planning and Reproductive Health

One of the primary drivers of growth in the global hormonal contraceptives market is the significant investment by governments and international health organizations in reproductive health and family planning programs. Hormonal contraceptives-including oral pills, patches, injections, implants, and vaginal rings-form the cornerstone of modern contraception. Their widespread availability and integration into public health systems are largely supported by government policies that aim to reduce unintended pregnancies, maternal mortality, and child morbidity. The World Health Organization (WHO) states that around 257 million women globally who want to avoid pregnancy are not using safe or modern contraceptive methods. To address this unmet need, numerous governments have scaled up access to hormonal contraceptives through national programs. For instance, the U.S. federal Title X Family Planning Program supports clinics in offering affordable or free birth control to low-income individuals. According to the Office of Population Affairs (OPA), Title X clinics served 1.5 million individuals in 2022 alone, and over 99% of those clients received contraceptive services.

In developing countries, such as India, the Ministry of Health and Family Welfare operates the National Family Planning Program, which provides subsidized contraceptives through public health centers. As of 2023, the Indian government distributed over 20 million cycles of oral contraceptive pills under its Mission Parivar Vikas scheme. These expansive efforts ensure continuous market demand for hormonal contraceptives and stimulate innovation and supply chain efficiency. In effect, public health policies aimed at increasing contraceptive prevalence are driving hormonal contraceptive market growth across regions.

Key Market Challenges

Health Risks and Side Effects Associated with Hormonal Contraceptives

Despite their widespread use and effectiveness, hormonal contraceptives are associated with various health risks and side effects, which pose a significant challenge to market growth. Hormonal contraceptives function by altering a woman's hormone levels to prevent ovulation, and this hormonal interference can lead to adverse effects such as mood swings, weight gain, nausea, headaches, and menstrual irregularities. More serious risks include an increased likelihood of blood clots, cardiovascular complications, and, in rare cases, certain types of cancer. A study by the National Cancer Institute (NCI) reported a slight increase in the risk of breast and cervical cancer among long-term users of hormonal contraceptives, although they may reduce the risk of ovarian and endometrial cancers.

In 2019, the U.S. Food and Drug Administration (FDA) updated warnings on combined hormonal contraceptives (CHCs) about the risk of venous thromboembolism (VTE), especially for products containing drospirenone. Similarly, regulatory agencies in Europe, such as the European Medicines Agency (EMA), have recommended stronger warnings and educational efforts to ensure informed use. Concerns about side effects can lead to discontinuation or switching to non-hormonal methods, particularly in high-risk populations such as smokers over 35, obese individuals, and those with hypertension or a family history of thrombotic disorders. These health considerations reduce user confidence and affect market penetration, especially among new adopters. As awareness of potential adverse effects grows, particularly through social media and health advocacy platforms, it may hinder widespread adoption unless offset by education, personalized medical guidance, and the development of safer formulations.

Key Market Trends

Increasing Preference for Long-Acting Reversible Contraceptives (LARCs)

A prominent trend reshaping the hormonal contraceptives landscape is the growing preference for Long-Acting Reversible Contraceptives (LARCs) such as hormonal intrauterine devices (IUDs) and subdermal implants. These methods offer extended protection ranging from three to ten years, minimal maintenance, and high efficacy-qualities that are increasingly appealing to women globally, particularly those seeking convenience and long-term reproductive autonomy. According to the U.S. Centers for Disease Control and Prevention (CDC), LARCs have the lowest failure rates among contraceptive methods-less than 1%-compared to 7% for oral contraceptive pills. This reliability, combined with a low requirement for user adherence, has fueled rapid adoption, especially in developed countries with well-established healthcare systems.

Government programs are also promoting LARCs as part of comprehensive reproductive healthcare. For instance, the UK's National Health Service (NHS) includes hormonal IUDs in its publicly funded contraceptive offerings. In the U.S., state-level Medicaid expansion has been linked to increased access and uptake of LARCs, particularly in underserved populations. A report from the Kaiser Family Foundation found that the use of LARCs among U.S. women aged 15-44 increased from 8.5% in 2009 to 14% in 2020. In low- and middle-income countries, international bodies like UNFPA and USAID have rolled out LARC-focused initiatives to reduce unmet contraceptive needs. These global efforts, combined with innovations in hormonal implant technologies, are likely to sustain the rising demand for LARCs over the coming decade.

Key Market Players

Report Scope:

In this report, the Global Hormonal Contraceptives Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hormonal Contraceptives Market, By Method:

Hormonal Contraceptives Market, By Hormone:

Hormonal Contraceptives Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Hormonal Contraceptives Market.

Available Customizations:

Global Hormonal Contraceptives Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Clinical Trial Analysis

6. Global Hormonal Contraceptives Market Outlook

7. North America Hormonal Contraceptives Market Outlook

8. Europe Hormonal Contraceptives Market Outlook

9. Asia-Pacific Hormonal Contraceptives Market Outlook

10. South America Hormonal Contraceptives Market Outlook

11. Middle East and Africa Hormonal Contraceptives Market Outlook

12. Market Dynamics

13. Market Trends & Developments

14. Porters Five Forces Analysis

15. SWOT Analysis: Global Hormonal Contraceptives Market

16. Competitive Landscape

17. Strategic Recommendations

18. About Us & Disclaimer

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â